Zydus Lifesciences Limited — Dividend/Bonus, 19-05-2026: Dividend

ZYDUS LIFESCIENCES has approved a final dividend of Re. 1 per equity share (100% on Re. 1 face value) for the financial year ending March 31, 2026. This payout is contingent on shareholder approval at the upcoming Annual General Meeting, scheduled for August 11, 2026. The company earlier held a board meeting where it reviewed and approved the financial results for the quarter and year ended March 31, 2026. This dividend signals a return to shareholders, pending their final vote. Keep an eye on the AGM for confirmation!